DIVERGENT EFFECTS OF SHORT-TERM, VERY-LOW-CALORIE DIET ON INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 SERUM CONCENTRATIONS IN PREMENOPAUSAL WOMEN WITH OBESITY
G. Depergola et al., DIVERGENT EFFECTS OF SHORT-TERM, VERY-LOW-CALORIE DIET ON INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-LIKE-GROWTH-FACTOR BINDING PROTEIN-3 SERUM CONCENTRATIONS IN PREMENOPAUSAL WOMEN WITH OBESITY, Obesity research, 6(6), 1998, pp. 408-415
Objective: Insulin-like growth factor-I (IGF-I) and insulinlike growth
factor binding protein-3 (IGFBP-3) serum concentrations provide a goo
d measure of the biological effects of growth hormone. The aims of the
present study were to: (1) investigate the associations of IGF-I and
IGFBP3 with body fat mass and distribution, and (2) evaluate the effec
ts of 3 weeks of very-low-calorie diet (VLCD) (318 kcal/day, with 40 g
protein, 35 g carbohydrate, and 2 g fat) on IGF-I and IGFBP-3 serum c
oncentrations. Research Methods and Procedures: The study was performe
d in 21 nondiabetic premenopausal women with obesity (body mass index
>27.0 kg/m(2); age: ranging from 18 to 48 years). Body fat mass and di
stribution were measured by computed tomography. Results: Before dieta
ry treatment, IGF-I and IGFBP-3 serum concentrations were inversely as
sociated with visceral adipose tissue (VAT) area (p<0.005 and p<0.05,
respec tively), but not with either total body fat or subcutaneous adi
pose tissue area. VLCD produced a significant decrease of body mass in
dex (p<0.001), total body fat (p<0.001), VAT (p<0.005), subcutaneous a
dipose tissue (p<0.001), IGF-I concentrations (p<0.05), and an increas
e of IGFBP-3 serum levels (p<0.001). The association of VAT with eithe
r IGF-I or IGFBP-3 serum concentrations was not maintained following V
LCD. Discussion: Our study suggests that visceral adipose tissue, rath
er than adiposity per se, accounts for IGF-I and IGFBP-3 serum concent
rations, and that rapid weight loss, possibly due to nutritional chang
es, results in lower IGF-I concentrations, higher IGFBP-3 concentratio
ns, and abrogation of the inverse associations of VAT with IGF-I and I
GFBP-3.